| Metric | Value ($ M) | Q2 FY25 | Q3 FY24 |
|---|---|---|---|
| Revenue | 13.29 | 15.7% | 40.2% |
| Total Income | 13.29 | 15.7% | 40.2% |
| Expenditure | 62.41 | 24.2% | 43.8% |
| PBT | -48.22 | 26.0% | 51.0% |
| Net Profit | -48.22 | 26.0% | 56.6% |
| OPM | — | ||
| NPM | — | ||
| EPS | -0.21 | 23.5% | 50.0% |
Gossamer Bio Reports Q3 2025 Financial Results
04 May 2026 · 4 May, 8:06 am
Summary
Gossamer Bio, Inc. issued a press release reporting its financial results for the quarter ended September 30, 2025. The press release is attached as an exhibit to the current report.
Informational and educational content only. Not investment advice.